InvestorsHub Logo
Followers 10
Posts 246
Boards Moderated 0
Alias Born 11/14/2019

Re: BGRDPL post# 79223

Thursday, 05/21/2020 11:16:36 AM

Thursday, May 21, 2020 11:16:36 AM

Post# of 233221
Nice find and positive on the drug but Dr. Seethamraju is taking a lot of the credit for himself and some of the claims related to the hospital's involvement are misleading. Specifically, I am referring to:

Based on the positive results with those patients, the FDA approved Dr. Seethamraju’s application for a phase 2 trial of leronlimab. That trial began enrolling both inpatients and outpatients with mild-to-moderate COVID-19 on April 2. A total of 75 will participate.



The above neglects to mention CytoDyn or Dr. Patterson. Seems to me that Dr. Seethamraju is trying to take more credit than he is due.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News